Studies of T cell reconstitution after hematopoietic stem cell transplant

被引:10
作者
Autran, B
Malphettes, M
Dhedin, N
Gorochov, G
Leblond, V
Debre, P
机构
关键词
T cell reconstitution; bone marrow transplantation; hematopoietic stem cell transplantation;
D O I
10.1007/s00282-997-0252-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hematopoietic stem cell (HSC) transplantation, whatever its conditions, is associated with an increased risk of infections and tumoral complications, because of a delayed immune reconstitution. T-cell regeneration has been mostly investigated and appears to come more from graft and/or host mature T-cells, rather than from the differentiation/maturation of reinfused progenitors. In allogeneic setting, the immune defect is enhanced by the immune host/donor conflict and the use of prophylactic or curative immunosuppressive therapy. The tools used. for studying post-transplant immunity are the following: immunophenotyping (kinetics and alterations of lymphocyte subset reconstitution), functional studies of T cell proliferation, cytokine production, cytotoxicity and signal transduction, as well as studies of T cell repertoire diversity. The CD4/CD8 cell immunophenotyping might be enough for routine clinical evaluation, allowing an adapted prophylaxis of opportunistic infections in those immune-suppressed patients, while functional assays Might be useful to evaluate the persistence overtime of defects in immune reconstitution. These overall assays are useful both for basic and clinical research and allow better understanding in the mechanisms for T cell regeneration in the diverse types of HSC transplants performed nowadays particularly after graft of purified HSC where immune reconstitution remains a key question.
引用
收藏
页码:252 / 256
页数:5
相关论文
共 44 条
  • [1] ANDERSON KC, 1990, BLOOD, V76, P235
  • [2] ASHIHARA E, 1994, BONE MARROW TRANSPL, V13, P377
  • [3] AUTRAN B, 1995, J IMMUNOL, V154, P1408
  • [4] AUTRAN B, 1991, BLOOD, V77, P2237
  • [5] AZOGUI O, 1983, J IMMUNOL, V131, P1205
  • [6] DEBRUIN HG, 1981, J IMMUNOL, V127, P244
  • [7] NATURAL-KILLER CELL-ACTIVITY IN HUMAN-BONE MARROW RECIPIENTS - EARLY REAPPEARANCE OF PERIPHERAL NATURAL-KILLER ACTIVITY IN GRAFT VERSUS HOST-DISEASE
    DOKHELAR, MC
    WIELS, J
    LIPINSKI, M
    TETAUD, C
    DEVERGIE, A
    GLUCKMAN, E
    TURSZ, T
    [J]. TRANSPLANTATION, 1981, 31 (01) : 61 - 65
  • [8] FAVROT M, 1983, CLIN EXP IMMUNOL, V54, P59
  • [9] FRIEDRICH W, 1982, BLOOD, V59, P696
  • [10] GOROCHOV G, 1994, BLOOD, V83, P587